P. Poortmans

Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?

Conny Vrieling, Laurence Collette, Alain Fourquet et al. · European Journal of Cancer · 2003 · 176 citations

Breast Oncology, Oncology, Pathology-related Characteristics +7

The Essential Role of Radiotherapy in the Treatment of Merkel Cell Carcinoma: A Study From the Rare Cancer Network

Pirus Ghadjar, Johannes H.A.M. Kaanders, P. Poortmans et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 73 citations

Rare Cancer Network, Essential Role, Radiation Therapy +7

Impact of a boost dose of 16 GY on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost’ trial

Harry Bartelink, Laurence Collette, Alain Fourquet et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 32 citations

Local Control, Breast Oncology, Oncology +6

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial

P. Poortmans, H. Bartelink, J.C. Horiot et al. · European Journal of Cancer Supplements · 2004 · 22 citations

Local Control, Breast Oncology, Breast Cancer +5

OC-0568: Accelerated PBI VS standard radiotherapy (IRMA trial): interim cosmetic and toxicity results

Bruno Meduri, A. Baldissera, M. Galeandro et al. · Radiotherapy and Oncology · 2017 · 22 citations · Full text